Identification of genetic and immune signatures for the recurrence of HER2-positive breast cancer after trastuzumab-based treatment [0.03%]
鉴定HER2阳性乳腺癌接受曲妥珠单抗治疗后的复发的遗传和免疫标志物
Chi Xu,Yahui Wang,Yuanyuan Hong et al.
Chi Xu et al.
Purpose: To determine the genetic and immune features associated with the recurrence of human epidermal growth factor receptor2-positive (HER2 +) breast cancer (BC) after trastuzumab-based treatment. ...
Patient reported symptom burden amongst immigrant and Canadian long-term resident women undergoing breast cancer surgery [0.03%]
接受乳腺癌手术的移民和加拿大长期居住女性患者症状负担研究
Elena Parvez,Megan Chu,David Kirkwood et al.
Elena Parvez et al.
Purpose: Immigrants are susceptible to marginalization due to social isolation, economic disadvantage and systemic bias. Our goal was to compare symptom burden between immigrant and long-term resident women undergoing bre...
Correction to: Genetic ablation of pregnancy zone protein promotes breast cancer progression by activating TGF-β/SMAD signaling [0.03%]
Correction to: 基因消融妊娠带蛋白通过激活TGF-β/SMAD信号促进乳腺癌进展
Rohit Kumar,Ekaterina Kuligina,Anna Sokolenko et al.
Rohit Kumar et al.
Letter to the editor regarding the article "pregnancy-associated breast cancer: a multicenter study comparing clinicopathological factors, diagnosis, and treatment outcomes with non-pregnant patients" [0.03%]
关于“与非孕期患者相比，孕期相关乳腺癌临床病理因素、诊断和治疗结果的多中心研究”一文的来信
Elham Sajjadi,Konstantinos Venetis,Nicola Fusco
Elham Sajjadi
Tara Ma,Caitlin R Semsarian,Alexandra Barratt et al.
Tara Ma et al.
Background: Population mammographic screening for breast cancer has led to large increases in the diagnosis and treatment of ductal carcinoma in situ (DCIS). Active surveillance has been proposed as a management strategy ...
Association between gout and subsequent breast cancer: a retrospective cohort study including 67,598 primary care patients in Germany [0.03%]
德国初级保健患者的痛风与随后发生的乳腺癌之间的关联：一项包含67598名患者的研究
Niklas Gremke,Sebastian Griewing,Karel Kostev et al.
Niklas Gremke et al.
Purpose: The aim of this retrospective cohort study was to analyze the cumulative incidence of breast cancer following gout and to investigate the association between gout and subsequent breast cancer in 67,598 primary ca...
Malignant phyllodes tumors of the breast: the malignancy grading and associations with prognosis [0.03%]
恶性叶状乳腺肿瘤的恶性分级及其与预后的相关性
Junjun Liu,Fangfang Li,Xuejing Liu et al.
Junjun Liu et al.
Purpose: This study aimed to correlate clinicopathological parameters with survival outcomes in a cohort of patients diagnosed with malignant phyllodes tumors (MPTs). We also analyzed the malignancy grade of MPTs and inve...
Tamoxifen pharmacokinetics and pharmacodynamics in older patients with non-metastatic breast cancer [0.03%]
老年非转移性乳腺癌患者他莫昔芬的药代动力学和药效学
E T D Souwer,A Sanchez-Spitman,D J A R Moes et al.
E T D Souwer et al.
Background: We aimed to study the pharmacokinetics and -dynamics of tamoxifen in older women with non-metastatic breast cancer. Methods: ...
A phase II study of neoadjuvant atezolizumab and nab-paclitaxel in patients with anthracycline-resistant early-stage triple-negative breast cancer [0.03%]
新辅助阿特朱单抗和白蛋白结合型紫杉醇治疗蒽环类药物耐药的早期三阴性乳腺癌患者II期研究
Clinton Yam,Elizabeth A Mittendorf,Haven R Garber et al.
Clinton Yam et al.
Purpose: Neoadjuvant anti-PD-(L)1 therapy improves the pathological complete response (pCR) rate in unselected triple-negative breast cancer (TNBC). Given the potential for long-term morbidity from immune-related adverse ...
High expression of the RET receptor tyrosine kinase and its ligand GDNF identifies a high-risk subset of estrogen receptor positive breast cancer [0.03%]
RET受体酪氨酸激酶及其配体GDNF的高表达可识别雌激素受体阳性乳腺癌的高度危险亚型
Rasha T Kakati,Hyunsoo Kim,Austin Whitman et al.
Rasha T Kakati et al.
Purpose: Resistance to endocrine therapy is the primary cause of treatment failure and death in patients with ER-positive (ER +)/luminal breast cancer. Expression and activation of the RET receptor tyrosine kinase may be ...